biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > RNAi

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon May 03, 2023 1:56pm

84 Views

Post# 35428024

RE:RE:RE:RE:RE:RNAi

Your lack of informed and critical thought, zwerp. is lazy, lamentable, off-putting. enervating, despicable, and boring.

On the other hand, there may be things in your life about which you do think in critical ways. Perhaps sports, beer, whatever. Start a blog about it. However, you ought to be careful about your habit of having only one thought and then repeating it to the exclusion of all else.

I mean, “I like beer,” can cause an audience to drift away after hearing it one or two hundred times. It’s sort of like saying “Bioasis is a scam and xB3 doesn’t work” over and over and over...

...and over.

jd